Vol. 59 No. 1 (2018): 2018591
2018591
Full Issue
PDF
E1
IMPACT OF ERYTHROCYTE SPECIES ON ASSAYS FOR INFLUENZA SEROLOGY
https://doi.org/10.15167/2421-4248/jpmh2018.59.1.870
PDF
E8
MEASLES OUTBREAK FROM FEBRUARY TO AUGUST 2017 IN MESSINA, ITALY
https://doi.org/10.15167/2421-4248/jpmh2018.59.1.853
PDF
E14
“PErCEIVE in Umbria”: Evaluation of anti-influenza vaccination's perception among Umbrian Pharmacists
https://doi.org/10.15167/2421-4248/jpmh2018.59.1.806
PDF
E20
PERCEIVED BARRIERS TO BREAST CANCER SCREENING AMONG SAUDI WOMEN AT PRIMARY CARE SETTING
https://doi.org/10.15167/2421-4248/jpmh2018.59.1.689
PDF
E30
Awareness and Knowledge about Cervical Cancer prevention methods among Tunisian women
https://doi.org/10.15167/2421-4248/jpmh2018.59.1.709
PDF
E36
Current data in Greek children indicate decreasing trends of obesity in the transition from childhood to adolescence; results from the EYZHN (National Action for Children’s Health) program
https://doi.org/10.15167/2421-4248/jpmh2018.59.1.797
PDF
E48
A screening focusing on alcohol consumption withdrawal effects in student’s population
https://doi.org/10.15167/2421-4248/jpmh2018.59.1.780
PDF
E63
ENERGY DRINK AND GINSENG CONSUMPTION BY ITALIAN UNIVERSITY STUDENTS: A CROSS-SECTIONAL STUDY
https://doi.org/10.15167/2421-4248/jpmh2018.59.1.813
PDF
E75
ENERGY DRINK CONSUMPTION: A SURVEY IN HIGH SCHOOL STUDENTS AND ASSOCIATED PSYCHOLOGICAL EFFECTS
https://doi.org/10.15167/2421-4248/jpmh2018.59.1.898
PDF
E80
Mental and physical effects of energy drinks consumption in an Italian young people group: a pilot study
https://doi.org/10.15167/2421-4248/jpmh2018.59.1.900
PDF
E88
EFFECTS OF ANTICOAGULATION THERAPY WITH VITAMIN K ANTAGONISTS ON HOSPITALIZATIONS AND EMERGENCY ROOM ACCESSES IN GROSSETO (ITALY)
https://doi.org/10.15167/2421-4248/jpmh2018.59.1.722
PDF
E92
Knowledge, attitude and practice about leptospirosis prevention among town service workers in northeastern Malaysia: a cross sectional study
https://doi.org/10.15167/2421-4248/jpmh2018.59.1.776
PDF
E99
Overview of Japanese encephalitis disease and its prevention. Focus on IC51 vaccine (Ixiaro®)
https://doi.org/10.15167/2421-4248/jpmh2018.59.1.962
PDF